Hanada R, Inaba T, Yaginuma A, Hayashi Y, Yamamoto K, Nishimoto H, Tsukiyama T
Saitama Children's Medical Center, Dept. of Haematology and Oncology.
Gan To Kagaku Ryoho. 1989 Feb;16(2):263-8.
Four pediatric patients with malignant brain tumors were treated with very high-dose etoposide plus very high-dose cyclophosphamide (HD-VP 16/CPM) followed by autologous bone marrow rescue. There were two brain stem gliomas, which were refractory to radiation therapy, ACNC, and beta-interferon and two relapsed malignant brain tumors. Both of the two with brain stem gliomas achieved response, one with clinical improvement and decrease of tumor size on CT scanning, the other with clinical improvement. Overall response duration was three months and nine months. Two patients with relapsed brain tumors received HD-VP 16/CPM as adjuvant chemotherapy. Low but significant levels of VP 16 and CPM were detected in CSF. Further investigation of HD-VP 16/CPM is needed as a chemotherapy for malignant brain tumors in children.
4例患有恶性脑肿瘤的儿科患者接受了大剂量依托泊苷加大剂量环磷酰胺(HD-VP 16/CPM)治疗,随后进行自体骨髓挽救。其中有2例脑干胶质瘤,对放射治疗、ACNC和β干扰素均无效,还有2例复发性恶性脑肿瘤。2例脑干胶质瘤患者均有反应,1例临床症状改善,CT扫描显示肿瘤大小减小,另1例临床症状改善。总体反应持续时间分别为3个月和9个月。2例复发性脑肿瘤患者接受HD-VP 16/CPM作为辅助化疗。在脑脊液中检测到低水平但显著的VP 16和CPM。需要进一步研究HD-VP 16/CPM作为儿童恶性脑肿瘤的化疗方法。